Harvard Bioscience Showcases Innovations at SOT
Harvard Bioscience, Inc. (NASDAQ: HBIO) has announced the exciting unveiling of its cutting-edge product innovations during the Society of Toxicology (SOT) conference. This prestigious event spans several days, allowing industry leaders to explore advancements that have the potential to revolutionize preclinical research and therapeutic development using organoids.
Innovating with SoHo™ Telemetry
Among the highlights is the advanced SoHo™ Implantable Real-Time Telemetry Platform. This telemetry solution is designed for researchers aiming to collect, manage, and analyze findings from multiple small animal models. This flexibility allows researchers to optimize their studies, catering to both shared housing and extended-range environmental needs.
Enhancing Research Efficiency
The SoHo biopotential monitoring devices are particularly beneficial in neurotoxicity and cardiovascular toxicology studies. Integrated with the GLP-compliant Ponemah data management platform, this system automates data collection, thereby minimizing manual effort and enhancing the consistency of results. Ultimately, this technology supports lower operating costs and faster test cycles, paving the way for greater testing throughput and the potential for AI-based analyses of preclinical datasets.
Pioneering the VivaMARS™ System
Another focus of Harvard Bioscience is its VivaMARS™ system, which offers a robust platform for real-time behavioral analysis. Powered by Ponemah, this solution addresses the needs of CROs and pharmaceutical companies, enabling them to reduce cycle times and enhance revenue streams in neuropharmacology and neurotoxicology applications.
Presentation Collaboration with a Leading CRO
On the conference's final day, March 20th, representatives will present a poster in collaboration with a prominent CRO that has been the first adopter of the VivaMARS technology. This showcases the system's practical applications and solidifies its value in the field.
Highlighting the Mesh MEA™ Organoid Platform
In addition to SoHo and VivaMARS, the Company will highlight the innovative Mesh Microelectrode Array (MEA) platform. This system is tailored for organoid applications, representing a significant leap in in vitro MEA technology.
Real-Time Insights into Organoid Functionality
The Mesh MEA™ system allows scientists to gather real-time electrophysiological data from living organoids. This capability is essential for addressing the increasing demand for organoid applications in research, safety pharmacology, and toxicology studies.
Advancing New Therapeutics
Jim Green, the CEO and Chairman of Harvard Bioscience, expressed his enthusiasm about the company's technologies impacting the biopharmaceutical industry positively. He emphasized how these innovations are designed not only to advance scientific understanding but also to minimize costs and expedite the time required to bring new drugs and therapies to market.
Visit Harvard Bioscience at the SOT
Attendees are welcome to visit Harvard Bioscience at booth #1411 in the Orange County Convention Center. The booth will be staffed throughout the SOT event, from March 17 to March 19, 2025, allowing visitors to engage with representatives and learn more about these remarkable innovations.
About Harvard Bioscience
Harvard Bioscience, Inc. is renowned for its role as a leader in developing and selling technologies and services that propel advances in life sciences. Their diverse customer base ranges from esteemed academic institutions to top-notch pharmaceutical and contract research organizations, establishing a solid reputation across North America, Europe, and China.
Frequently Asked Questions
What will Harvard Bioscience showcase at the SOT conference?
They will present innovations including the SoHo™ telemetry platform, VivaMARS™ system, and Mesh MEA™ platform.
When is the Society of Toxicology meeting occurring?
The SOT meeting takes place from March 17-20, 2025.
What is the purpose of the SoHo™ platform?
The SoHo™ platform is designed to assist researchers in collecting and analyzing data across multiple small animal models.
How does VivaMARS™ benefit pharmaceutical companies?
It enables real-time behavioral analysis, helping reduce cycle times and increasing revenue in drug development.
Where can I visit Harvard Bioscience during the SOT?
Their booth is located at #1411 at the Orange County Convention Center.
